P15121 (ALDR_HUMAN) Homo sapiens (Human)
Aldo-keto reductase family 1 member B1 UniProtKBInterProSTRINGInteractive Modelling
316 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
175 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE | homo-2-mer | 100 | 2×NAP; 2×FID; | |||
| Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5… | monomer | 99.68 | 1×NAP; 1×4O8; | |||
| Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S) at 0.7… | monomer | 99.68 | 1×NAP; 1×CIT; 1×FIS; | |||
| Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoy… | monomer | 99.68 | 1×NAP; 1×M15; | |||
| Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carba… | monomer | 99.68 | 1×NAP; 1×1WX; | |||
| Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carb… | monomer | 99.68 | 1×NAP; 1×4O9; | |||
| Human aldose reductase in complex with NADP and citrate at 0.82 angstrom | monomer | 99.68 | 1×NAP; 2×FLC; | |||
| Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenox… | monomer | 99.68 | 1×NAP; 1×W8X; | |||
| Crystal structure of human Aldose Reductase complexed with NADP+ and JF0064 | monomer | 99.68 | 1×NAP; 1×64I; | |||
| Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy… | monomer | 99.68 | 1×NAP; 1×1WW; | |||
| Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a… | monomer | 99.68 | 1×CL; 1×NDP; 1×LDT; 1×FID; 2×CIT; | |||
| Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a… | monomer | 99.68 | 1×CL; 1×NDP; 1×LDT; 1×FID; 1×CIT; | |||
| Crystal structure of human Aldose Reductase complexed with NADP and Fidarestat | monomer | 99.68 | 1×CL; 1×NAP; 1×FID; | |||
| AKR1B1 at 0.03 MGy radiation dose. | monomer | 99.68 | 1×NAP; 2×CIT; | |||
| human Aldose Reductase in complex with SAR25 | monomer | 99.68 | 1×NAP; 1×CIT; 1×M0K; | |||
| Structure of Human Aldose Reductase Mutant L300G with a Citrate Molecule Bound in the Anion Binding… | monomer | 99.37 | 1×NAP; 2×CIT; | |||
| Crystal structure of human AKR1B1 complexed with NADP+ and compound 37 | monomer | 99.68 | 1×NAP; 1×AV5; | |||
| Human Aldose Reductase Mutant L300G in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy… | monomer | 99.37 | 1×NAP; 1×4G7; 1×CIT; | |||
| Human Aldose Reductase mutant T113V complexed with IDD388 | monomer | 99.37 | 1×NAP; 1×388; 1×CIT; 1×BR; | |||
| Human Aldose Reductase Mutant L300/301A in Complex with a Ligand with an IDD Structure (3-({[2-(car… | monomer | 99.05 | 2×4G7; 1×CIT; 1×NAP; | |||
| Human Aldose Reductase Mutant L300G in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3… | monomer | 99.37 | 1×NAP; 1×30L; 1×CIT; | |||
| Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy… | monomer | 99.37 | 1×CIT; 1×4G7; 1×2WR; 1×NAP; | |||
| Human Aldose Reductase Mutant A299G in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3… | monomer | 99.37 | 1×NAP; 1×30L; 1×CIT; | |||
| Human Aldose Reductase Mutant A299G in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy… | monomer | 99.37 | 1×NAP; 1×CIT; 1×4G7; | |||
| Human Aldose Reductase in Complex with a Hydroxyphenyl-Thiophen-Acid Inhibitor (Schl32357) | monomer | 99.68 | 1×NAP; 1×LZO; 1×DMS; | |||
| Crystal structure of human AKR1B1 complexed with NADP+ and compound 41 | monomer | 99.68 | 1×NAP; 1×AVT; | |||
| Human Aldose Reductase complexed with Schl12221 ({2-[5-(3-NITROPHENYL)FURAN-2-YL]PHENYL}ACETIC ACID… | monomer | 99.68 | 1×NAP; 1×2WB; | |||
| Structure of Human Aldose Reductase Mutant A299G/L300A with a Citrate Molecule Bound in the Anion B… | monomer | 99.05 | 1×NAP; 2×CIT; 1×PEG; | |||
| Crystal structure of human AKR1B1 complexed with NADP+ and compound 39 | monomer | 99.68 | 1×NAP; 1×AW8; | |||
| AKR1B1 at 0.75 MGy radiation dose. | monomer | 99.68 | 1×NAP; 2×CIT; | |||
| Structure of Human Aldose Reductase Mutant A299G with a Citrate Molecule Bound in the Anion Binding… | monomer | 99.37 | 1×NAP; 2×CIT; | |||
| Human Aldose Reductase Mutant L301A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3… | monomer | 99.37 | 1×30L; 1×CIT; 1×NAP; | |||
| Human Aldose Reductase Mutant L300/301A in Complex with a Ligand with an IDD Structure ({5-fluoro-2… | monomer | 99.05 | 1×30L; 1×CIT; 1×NAP; | |||
| Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3… | monomer | 99.37 | 1×NAP; 2×30L; 1×CIT; | |||
| Human Aldose Reductase in Complex with a Ligand with a Fluoro-Indol-Acetic-Acid Structure (Schl4417… | monomer | 99.68 | 1×NAP; 2×QXO; 1×DMS; 1×CIT; 1×PEG; | |||
| Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)c… | monomer | 99.68 | 1×NAP; 1×30L; 1×CIT; | |||
| Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe… | monomer | 99.68 | 1×NDP; 1×LDT; 1×CIT; | |||
| Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe… | monomer | 99.68 | 1×NDP; 1×LDT; 1×CIT; | |||
| The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specificity … | monomer | 99.68 | 1×NAP; 1×393; | |||
| Crystal structure of human Aldose Reductase complexed with NADP+ and JF0048 | monomer | 99.68 | 1×NAP; 1×48I; | |||
| Aldose Reductase Mutant Leu 300 Pro complexed with Fidarestat | monomer | 99.37 | 1×CL; 1×NAP; 1×FID; 1×CIT; | |||
| Human Aldose Reductase Mutant L301A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy… | monomer | 99.37 | 1×4G7; 1×CIT; 1×NAP; | |||
| Human Aldose Reductase complexed with Schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) at … | monomer | 99.68 | 1×NAP; 1×53N; | |||
| Human Aldose Reductase Mutant A299G/L300G in Complex with a Ligand with an IDD Structure (3-({[2-(c… | monomer | 99.05 | 1×NAP; 1×4G7; 1×CIT; | |||
| AKR1B1 at 1.65 MGy radiation dose. | monomer | 99.68 | 1×NAP; 2×CIT; | |||
| Human Aldose Reductase Mutant A299G/L300A in Complex with a Ligand with an IDD Structure ({5-fluoro… | monomer | 99.05 | 1×NAP; 1×30L; 1×CIT; | |||
| Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrom | monomer | 99.68 | 1×NDP; 1×3NA; | |||
| Crystal structure of human aldose reductase complexed with NADP and IDD552 | monomer | 99.68 | 1×NAP; 1×ID5; | |||
| Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylme… | monomer | 99.68 | 1×NAP; 1×37V; | |||
| Human Aldose Reductase mutant T113V in complex with Zopolrestat | monomer | 99.37 | 1×NAP; 1×ZST; | |||
| Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A. | monomer | 99.68 | 1×NAP; 1×4G7; | |||
| AKR1B1 at 2.55 MGy radiation dose. | monomer | 99.68 | 1×NAP; 2×CIT; | |||
| Crystal structure of human Aldose Reductase complexed with NADP and Minalrestat | monomer | 99.68 | 1×BFI; 1×NAP; | |||
| Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe… | monomer | 99.68 | 1×NDP; 1×LDT; 1×CIT; | |||
| Structure of Human Aldose Reductase Mutant L301A with a Citrate Molecule Bound in the Anion Binding… | monomer | 99.37 | 2×CIT; 1×NAP; | |||
| Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcar… | monomer | 99.68 | 1×2WQ; 1×CIT; 1×NAP; | |||
| Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-pheno… | monomer | 99.68 | 1×NAP; 1×2WR; | |||
| Human Aldose Reductase mutant T113V in complex with IDD393 crystallized in spacegroup P1 | monomer | 99.37 | 1×NAP; 1×393; | |||
| Human Aldose Reductase in complex with ALR43 | monomer | 99.68 | 1×CIT; 1×NAP; 1×NXQ; | |||
| Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe… | monomer | 99.68 | 1×NDP; 1×LDT; 1×CIT; | |||
| Human Aldose Reductase Mutant A299G/L300A in Complex with a Ligand with an IDD Structure (3-({[2-(c… | monomer | 99.05 | 1×NAP; 1×CIT; 1×4G7; | |||
| Human Aldose Reductase complexed with a ligand with a new scaffold at 1.26 A | monomer | 99.68 | 1×NAP; 2×3E2; | |||
| Structure of Human Aldose Reductase Mutant L300A with a Citrate Molecule Bound in the Anion Binding… | monomer | 99.37 | 2×CIT; 1×NAP; | |||
| Human aldose reductase in complex with a nitrile-containing IDD inhibitor | monomer | 99.68 | 1×NAP; 1×3T4; 1×CIT; | |||
| Human aldose reductase mutant T113V complexed with IDD393 | monomer | 99.37 | 1×NAP; 1×393; | |||
| Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S) | monomer | 99.68 | 1×NAP; 1×CIT; 1×FIS; | |||
| Crystal structure of Aldose Reductase complexed with 2R4S (Stereoisomer of Fidarestat, 2S4S) | monomer | 99.68 | 1×NAP; 1×FIR; | |||
| Crystal structure of Aldose Reductase with citrates bound in the active site | monomer | 99.68 | 1×NAP; 2×CIT; | |||
| Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitor | monomer | 99.68 | 1×NAP; 1×62P; | |||
| Aldose reductase complexed with nitrophenyl-oxadiazol type inhibitor at 1.43 A | monomer | 99.68 | 1×NAP; 1×BTO; | |||
| Human Aldose Reductase complexed with four tolrestat molecules at 1.5 A resolution. | monomer | 99.68 | 1×NAP; 4×TOL; | |||
| Human Aldose Reductase C298S mutant in Complex with NADP+ in Space Group P212121 | monomer | 99.37 | 1×NAP; 4×SO4; | |||
| Human Aldose Reductase in Complex with NADP+ and WY14643 in Space Group P212121 | monomer | 99.68 | 1×NAP; 1×WY1; 4×SO4; | |||
| Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductase | monomer | 99.68 | 1×NAP; 2×DOY; | |||
| Structure of Human Aldose Reductase Mutant L300/301A with a Citrate Molecule Bound in the Anion Bin… | monomer | 99.05 | 1×CIT; 1×NAP; | |||
| HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR | monomer | 100 | 1×NAP; 1×I84; | |||
| Human aldose reductase complexed with IDD 740 inhibitor | monomer | 99.68 | 1×NDP; 1×Q74; | |||
| Crystal Structure of Human Aldose Reductase Complexed with Tolmetin | monomer | 100 | 1×NAP; 1×TLT; | |||
| Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5 | monomer | 100 | 1×NAP; 1×ID5; | |||
| Aldose reductase complexed with a nitro compound | monomer | 100 | 1×NAP; 1×NTI; 23×DMF; | |||
| Crystal Structure of Human Aldose Reductase Complexed with Sulindac Sulfone | monomer | 100 | 1×NAP; 1×SLO; | |||
| Crystal Structure of Human Aldose Reductase Complexed with Sulindac | monomer | 100 | 1×NAP; 1×SUZ; | |||
| Aldose reductase complexed with glceraldehyde | monomer | 100 | 1×NAP; 1×3GR; 1×0PY; | |||
| Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfide | monomer | 100 | 1×NAP; 1×SFI; | |||
| Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And Epalrestat | monomer | 100 | 1×EPR; 2×SO4; 1×NAP; | |||
| Human Aldose Reductase in Complex with NADP+ in Space Group P212121 | monomer | 99.68 | 1×NAP; 5×SO4; 1×GOL; | |||
| Crystal structure of human Aldose Reductase complexed with NADP+ and JF0049 | monomer | 99.68 | 1×NAP; 1×F49; | |||
| Human Aldose Reductase structure | monomer | 100 | 1×NAP; 1×LDT; | |||
| Complex of Aldose Reductase with inhibitor IDD 1219 | monomer | 99.68 | 1×NAP; 1×2X9; | |||
| Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitor | monomer | 99.68 | 1×NAP; 1×62P; | |||
| Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution | monomer | 99.68 | 1×NAP; 2×PEG; 2×PG5; 1×CIT; 1×SUZ; 1×PG4; | |||
| Human Aldose Reductase complexed with Schl7815 ((3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID)at 1… | monomer | 99.68 | 1×NAP; 1×2W9; | |||
| Human Aldose Reductase complexed with Schl7802 at 1.06 A | monomer | 99.68 | 1×NAP; 1×2W8; | |||
| Human aldose reductase mutant T113C complexed with IDD594 | monomer | 99.36 | 1×NAP; 1×LDT; 1×CIT; 1×BR; | |||
| Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluoro… | monomer | 99.68 | 1×NAP; 1×2YZ; | |||
| Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And AT-003 | monomer | 100 | 1×NAP; 1×XY0; 3×EDO; | |||
| Aldose Reductase in complex with novel biarylic inhibitor | monomer | 99.68 | 1×NAP; 1×53N; | |||
| Human aldose reductase mutant L300P complexed with uracil-type inhibitor at 1.45 A. | monomer | 99.36 | 1×NAP; 1×47D; | |||
| Human aldose reductase mutant L301M complexed with tolrestat. | monomer | 99.36 | 1×NAP; 1×TOL; | |||
| Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking). | monomer | 99.68 | 1×NAP; 1×ZST; | |||
| Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 A | monomer | 99.68 | 1×NAP; 1×LIT; | |||
| Human aldose reductase mutant V47I complexed with fidarestat. | monomer | 99.36 | 1×NAP; 1×FID; | |||
| Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2) | monomer | 99.68 | 1×NAP; 3×ITB; | |||
| Human aldose reductase mutant C303D complexed with IDD393. | monomer | 99.36 | 1×NAP; 1×393; | |||
| Human aldose reductase mutant C303D complexed with fidarestat. | monomer | 99.36 | 1×NAP; 1×FID; | |||
| Human aldose reductase complexed with nitro-substituted IDD-type inhibitor | monomer | 99.68 | 1×NAP; 1×393; | |||
| Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A. | monomer | 99.36 | 1×NAP; 1×ZST; | |||
| Human aldose reductase mutant L301M complexed with sorbinil. | monomer | 99.36 | 1×NAP; 1×SBI; | |||
| Human aldose reductase mutant L300A complexed with IDD393. | monomer | 99.36 | 1×NAP; 1×393; | |||
| Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocrys… | monomer | 99.68 | 1×NAP; 1×ZST; | |||
| Human aldose reductase mutant V47I complexed with zopolrestat | monomer | 99.36 | 1×NAP; 1×ZST; | |||
| Human aldose reductase mutant F121P complexed with zopolrestat. | monomer | 99.36 | 1×NAP; 1×ZST; | |||
| Crystal structure of human Aldose Reductase complexed with zopolrestat after 3 days soaking (3days_… | monomer | 99.68 | 1×NAP; 1×ZST; | |||
| Human Aldose Reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2) | monomer | 99.68 | 1×NAP; 1×ZST; | |||
| Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking. | monomer | 99.68 | 1×NAP; 1×ZST; | |||
| Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And AT-003 Soaked In Hydrogen P… | monomer | 100 | 1×NAP; 1×XY0; 4×EDO; 13×PEO; | |||
| Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And AT-001 | monomer | 100 | 1×NAP; 1×XXQ; | |||
| Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3) | monomer | 99.68 | 1×NAP; 1×ITA; | |||
| Human aldose reductase mutant F121P complexed with IDD393. | monomer | 99.36 | 1×NAP; 1×393; | |||
| Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst) | monomer | 99.68 | 1×NAP; 1×ZST; | |||
| Human aldose reductase mutant S302R complexed with IDD 393. | monomer | 99.36 | 1×NAP; 1×393; | |||
| Human aldose reductase double mutant S302R-C303D complexed with fidarestat. | monomer | 99.05 | 1×NAP; 1×FID; | |||
| AN UNLIKELY SUGAR SUBSTRATE SITE IN THE 1.65 ANGSTROMS STRUCTURE OF THE HUMAN ALDOSE REDUCTASE HOLO… | monomer | 100 | 1×NAP; | |||
| Crystal Structure of Aldose Reductase complexed with Dichlorophenylacetic acid | monomer | 99.05 | 1×NAP; 1×2CL; | |||
| Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And AT-007 | monomer | 100 | 1×NAP; 1×XYK; 5×EDO; | |||
| Human aldose reductase mutant S302R complexed with uracil-type inhibitor. | monomer | 99.36 | 1×NAP; 1×47D; | |||
| Human aldose reductase mutant C303D complexed with uracil-type inhibitor. | monomer | 99.36 | 1×NAP; 1×47D; | |||
| Human aldose reductase mutant S302R complexed with zopolrestat. | monomer | 99.36 | 1×NAP; 1×ZST; | |||
| AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT… | monomer | 100 | 1×CAC; 1×NAP; | |||
| TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN T… | monomer | 99.68 | 1×NAP; 1×CIT; | |||
| AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT… | monomer | 100 | 1×G6P; 1×NAP; | |||
| REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOL… | monomer | 100 | 1×NAP; 1×ZST; | |||
| Aldose reductase tertiary complex with NADPH and DEG | monomer | 100 | 1×NDP; 1×TGG; | |||
| Crystal Structure of Aldose Reductase complexed with 2-Hydroxyphenylacetic Acid | monomer | 100 | 1×NAP; 1×OHP; | |||
| Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And Two AT-001 | monomer | 100 | 1×NAP; 2×XXQ; 3×EDO; | |||
| Crystal Structure of Aldose Reductase complexed with Lipoic Acid | monomer | 100 | 1×NAP; 1×LPA; | |||
| Apo R268A human aldose reductase | monomer | 99.68 | ||||
| CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT. | monomer | 100 | 1×NAP; 1×ZES; | |||
| Human Aldose Reductase in complex with NADP+ and the inhibitor IDD594 at 0.66 Angstrom | monomer | 99.68 | 1×NDP; 1×LDT; 2×CIT; | |||
| Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15K | monomer | 99.68 | 1×NDP; 1×LDT; 2×CIT; | |||
| Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60K | monomer | 99.68 | 1×NDP; 1×LDT; 2×CIT; | |||
| Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a… | monomer | 99.68 | 1×CL; 1×NDP; 1×LDT; 1×FID; 2×CIT; | |||
| Crystal structure of human AR complexed with NADP+ and AK198 | monomer | 99.68 | 1×NAP; 1×I98; | |||
| Human Aldose Reductase mutant T113C in complex with IDD388 | monomer | 99.36 | 1×NAP; 1×388; 1×BR; 1×CIT; | |||
| Human Aldose Reductase complexed with Schl7764 at 1.12 A | monomer | 99.68 | 1×2HZ; 1×NAP; | |||
| AKR1B1 at 3.45 MGy radiation dose. | monomer | 99.67 | 1×NAP; 1×CIT; | |||
| Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1) | monomer | 99.68 | 1×3UH; 1×NAP; | |||
| Human Aldose Reductase mutant T113S complexed with Zopolrestat | monomer | 99.36 | 1×NAP; 1×ZST; | |||
| Human aldose reductase with uracil-type inhibitor at 1.42A. | monomer | 99.68 | 1×NAP; 1×47D; | |||
| Human aldose reductase mutant L300P complexed with zopolrestat. | monomer | 99.36 | 1×NAP; 1×ZST; | |||
| Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_… | monomer | 99.68 | 1×NAP; 1×ZST; | |||
| Human Aldose Reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2) | monomer | 99.68 | 1×NAP; 1×ZST; | |||
| Human Aldose Reductase mutant T113A complexed with Zopolrestat | monomer | 99.36 | 1×NAP; 1×ZST; | |||
| AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT… | monomer | 100 | 1×NAP; 1×CIT; | |||
| ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE | monomer | 99.36 | 1×NAP; 2×ALR; | |||
| Crystal Structure of Aldose Reductase complexed with Phenylacetic Acid | monomer | 100 | 1×NAP; 1×PAC; | |||
| Crystal Structure of Aldose Reductase complexed with Hexanoic Acid | monomer | 100 | 1×NAP; 1×6NA; | |||
| Crystal Structure of C298A W219Y Aldose Reductase complexed with Phenylacetic Acid | monomer | 99.36 | 1×NAP; 1×PAC; | |||
| Crystal Structure of C298A W219Y Aldose Reductase complexed with Dichlorophenylacetic acid | monomer | 99.35 | 1×NAP; 1×2CL; | |||
| THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX | monomer | 99.67 | 1×NDP; | |||
| CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE | monomer | 99.36 | 1×NAP; 1×CIT; | |||
| Perdeuterated alr2 in complex with idd594 | monomer | 99.68 | 1×NDP; 1×LDT; 2×CIT; | |||
| Structure of Human Aldose Reductase Mutant A299G/L300G with a Citrate Molecule Bound in the Anion B… | monomer | 99.04 | 1×NAP; 2×CIT; | |||
| Human aldose reductase mutant T113V complexed with IDD594 | monomer | 99.36 | 1×NAP; 1×LDT; 1×CIT; | |||
| Human Aldose Reductase Mutant A299G/L300G in Complex with a Ligand with an IDD Structure ({5-fluoro… | monomer | 99.04 | 1×NAP; 1×30L; 2×CIT; | |||
| Human aldose reductase mutant T113S complexed with IDD388 | monomer | 99.36 | 1×NAP; 1×388; 1×BR; 1×CIT; | |||
| Human Aldose Reductase in complex with ALR25 | monomer | 99.68 | 1×CIT; 1×NXK; 1×NAP; | |||
| Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mu… | monomer | 99.36 | 1×NAP; 1×LDT; 1×BR; 1×CIT; | |||
| Human aldose reductase complexed with tolrestat at 1.08 A resolution. | monomer | 99.68 | 1×NAP; 1×TOL; | |||
| Human Aldose Reductase mutant T113A complexed with IDD 594 | monomer | 99.36 | 1×NAP; 1×LDT; 1×CIT; 1×BR; | |||
| Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mu… | monomer | 99.36 | 1×NAP; 1×LDT; 1×BR; 1×CIT; | |||
| Human aldose reductase double mutant S302R-C303D complexed with zopolrestat. | monomer | 99.04 | 1×NAP; 1×ZST; | |||
| Human aldose reductase mutant T113S complexed with IDD594 | monomer | 99.36 | 1×NAP; 1×LDT; 1×CIT; 1×BR; | |||
| Human aldose reductase mutant T113A complexed with IDD388 | monomer | 99.36 | 1×NAP; 1×388; 1×BR; | |||
| Human aldose reductase complexed with halogenated IDD-type inhibitor | monomer | 99.68 | 1×NAP; 1×388; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1x96.1.A | monomer | 0.89 | 1×NAP; | 99.68 | ||